跳转至内容
Merck
CN

MABT207

Anti-Integrin αV (ITGAV/CD51) Antibody

mouse monoclonal, 272-17E6

别名:

Integrin alpha-V, Vitronectin receptor subunit alpha, CD51, Integrin alpha-V heavy chain, Integrin alpha-V light chain, Intergrin av

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Clone:
272-17E6, monoclonal
Species reactivity:
human
Application:
FACS, IP, activity assay
Citations:
9
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

抗-整合素α-V抗体,克隆272-17E6(不含叠氮化物), clone 272-17E6, from mouse

biological source

mouse

Quality Level

antibody form

purified antibody

antibody product type

primary antibodies

clone

272-17E6, monoclonal

species reactivity

human

technique(s)

activity assay: suitable, flow cytometry: suitable, immunoprecipitation (IP): suitable

isotype

IgG1κ

NCBI accession no.

UniProt accession no.

shipped in

wet ice

target post-translational modification

unmodified

Gene Information

human ... ITGAV(3685)

General description

整合素α-v(或CD51;玻连蛋白受体亚基α)蛋白是介导细胞彼此之间以及与细胞外基质之间粘附的跨膜受体。整合素受体被多种细胞内信号激活,这些信号修饰其胞质结构域并诱导整合素分子的构型变化,从而使配体与细胞外表面结合。该过程的重要部分是肌动蛋白、踝蛋白与整合素胞质域的结合。
计算分子量116 kDa

Immunogen

人胎盘ɑvβ3

Application

免疫沉淀分析: 一个代表性批次已被独立实验室用于检测M21细胞裂解物中的整合素α-V。(Mitjans, F., et al (1995).Journal of Cell Science.108:2825-2838.)
抗整合素α-v抗体,克隆272-17E6(不含叠氮化物)可检测整合素α-V的水平,&已发布&验证可用于流式细胞术、免疫沉淀和活性测定。
研究子类别
粘附(CAMs)
研究类别
细胞结构

Physical form

形式:纯化
纯化的小鼠单克隆IgG1κ,溶于不含防腐剂的PBS缓冲液中。
纯化蛋白G

Preparation Note

自接收之日起,在-20°C下可稳定保存1年。
处理建议: 收到后,在取下瓶盖之前,将小瓶离心并轻轻混合溶液。分装至微量离心管中,并储存于-20°C。避免反复冻融循环,否则可能损坏IgG并影响产品性能。

Analysis Note

对照
HeLa细胞
通过流式细胞术在HeLa细胞中进行评价。

流式细胞术分析: 0.5 µg该抗体在HeLa细胞中检测到整合素α-v。

Other Notes

浓度:关于批次特定浓度请参见检验报告。

Disclaimer

除非我们的目录或产品随附的其他公司文件中另有说明,否则我们的产品预期仅用于研究用途,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。


Still not finding the right product?

或者

试用我们的 产品选型工具 工具缩小选择范围


存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable



分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容

New Products: Antibodies, Assays, Small Molecules, Inhibitors, and Proteins


Khalil Zaman et al.
International journal of cancer, 118(3), 755-764 (2005-08-23)
Anti-angiogenic therapies are currently in cancer clinical trials, but to date there are no established tests for evaluating the angiogenic status of a patient. We measured 11 circulating angiogenesis-associated molecules in cancer patients before and after local treatment. The purpose
F Mitjans et al.
Journal of cell science, 108 ( Pt 8), 2825-2838 (1995-08-01)
A series of murine monoclonal antibodies were raised against purified human alpha v beta 3 integrin and against M21 human melanoma cells. Five notable hybridomas were identified by ELISA on purified integrins, and the isolated antibodies bound the alpha v-chain.
Maria Rita Milone et al.
Oncotarget, 6(7), 5324-5341 (2014-12-08)
Proteomic analysis identified differentially expressed proteins between zoledronic acid-resistant and aggressive DU145R80 prostate cancer (PCa) cells and their parental DU145 cells. Ingenuity Pathway Analysis (IPA) showed a strong relationship between the identified proteins within a network associated with cancer and



全球贸易项目编号

货号GTIN
MABT20704053252596001